#

External COLLABORATION

Company Profile
2019
Huaota entered into an agreement with Shanghai Junshi Biosciences Co., Ltd and Junshi acquired the Avastin monoclonal antibody biosimilar (project code "HOT-1010") from Huaota for ￥90 million.HOT-1010
2019
2017
 Huaota reached a license agreement with Eutilex CO., LTD.
of HOT-1030 project, a CD137 monoclonal antibody.
2017
2013

Huaota licensed in four biosimilar products from US Oncobiologics Inc. 

including Adalimumab monoclonal antibody biosimilar (project code ‘HOT-3010’) and Avastin monoclonal antibody biosimilar (project code ‘HOT-1010’)

2013